Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Snell

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Expert Opinion on Pharmacotherapy|August 29, 2003
Tuberculosis susceptibility--implications for drug development and therapyNoel J C Snell
Journal of Virology|August 28, 2004
Ribavirin therapy for Nipah virus infectionN J C Snell
Drug Discovery Today|January 28, 2003
Examining unmet needs in infectious diseaseNoel J C Snell
Experimental Lung Research|December 14, 2007
Host defenses against respiratory tract infection: implications for anti-inflammatory drug development and treatmentN J C Snell
Expert Opinion on Investigational Drugs|February 5, 2014
Discontinued drug projects in the respiratory therapeutic area during 2012Noel J C Snell
Psychology (Savannah, Ga.)|September 26, 2003
Prisonomics and the use of psychotropic drugs on incarcerated offenders: ethical considerationsM E Marsh, J C Snell, W Wakefield
Journal of Leukocyte Biology|October 23, 1997
Polyribonucleotides induce nitric oxide production by human monocyte-derived macrophagesJ C Snell, O Chernyshev, D L Gilbert, et al.
Free Radical Biology & Medicine|January 1, 1996
Location-dependent artifact for no measurement using multiwell platesJ C Snell, C A Colton, O N Chernyshev, et al.
Peptides|November 1, 1993
MK-329 blocks the inhibition of alcohol intake by CCK-8B A Carr, J D Ballou, J C Snell, et al.
Respiratory Medicine|June 12, 2004
Summary of recommendations for the design of clinical trials and the registration of drugs used in the treatment of asthmaS T Holgate, J Bousquet, K F Chung, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Expert Opinion on Pharmacotherapy|August 29, 2003
Tuberculosis susceptibility--implications for drug development and therapyNoel J C Snell
Journal of Virology|August 28, 2004
Ribavirin therapy for Nipah virus infectionN J C Snell
Drug Discovery Today|January 28, 2003
Examining unmet needs in infectious diseaseNoel J C Snell
Experimental Lung Research|December 14, 2007
Host defenses against respiratory tract infection: implications for anti-inflammatory drug development and treatmentN J C Snell
Expert Opinion on Investigational Drugs|February 5, 2014
Discontinued drug projects in the respiratory therapeutic area during 2012Noel J C Snell
Psychology (Savannah, Ga.)|September 26, 2003
Prisonomics and the use of psychotropic drugs on incarcerated offenders: ethical considerationsM E Marsh, J C Snell, W Wakefield
Journal of Leukocyte Biology|October 23, 1997
Polyribonucleotides induce nitric oxide production by human monocyte-derived macrophagesJ C Snell, O Chernyshev, D L Gilbert, et al.
Free Radical Biology & Medicine|January 1, 1996
Location-dependent artifact for no measurement using multiwell platesJ C Snell, C A Colton, O N Chernyshev, et al.
Peptides|November 1, 1993
MK-329 blocks the inhibition of alcohol intake by CCK-8B A Carr, J D Ballou, J C Snell, et al.
Respiratory Medicine|June 12, 2004
Summary of recommendations for the design of clinical trials and the registration of drugs used in the treatment of asthmaS T Holgate, J Bousquet, K F Chung, et al.
Pageof 1